NASDAQ:FBRX | Free Cash Flow | Forte Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$18.81M$0.00-$18.81M
2025-12-31-$16.47M$0.00-$16.47M
2025-03-31-$10.36M$61,000.00-$10.42M
2024-12-31-$10.01M$31,000.00-$10.04M
2024-03-31-$6.67M$6,000.00-$6.67M
2023-12-31-$8.97M$17,000.00-$8.99M
2023-03-31-$5.2M
2022-12-31-$2.89M
2022-03-31-$1.98M
2021-12-31-$3.58M
2021-03-31-$4.03M
2020-12-31-$3.8M
2020-03-31-$2.87M
2019-12-31-$653,000.00$89,000.00-$742,000.00
2019-03-31-$17.68M$133,000.00-$17.82M
2018-12-31-$11.94M$472,000.00-$12.42M
2018-03-31-$12.71M$220,000.00-$12.93M
2017-12-31-$9.17M$318,000.00-$9.49M
2017-03-31-$7.57M$53,000.00-$7.62M
2016-12-31-$7.75M$10,000.00-$7.76M
2016-03-31-$6.07M$41,000.00-$6.11M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$50.88M$116,000.00-$51M
2024-12-31-$30.75M$37,000.00-$30.78M
2023-12-31-$28.71M$88,000.00-$28.79M
2022-12-31-$8.19M
2021-12-31-$16.68M
2020-12-31-$18.42M
2019-12-31-$2.77M$162,000.00-$2.93M
2018-12-31-$34.47M$1.97M-$36.44M
2017-12-31-$31.13M$655,000.00-$31.79M
2016-12-31-$29.54M$525,000.00-$30.06M
2015-12-31-$21.04M$231,000.00-$21.27M